Fundraising Fox

Remedium

Boston, US · Founded 2020 · 20 employees on LinkedIn · 5 known investors

Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein. Its work targets diseases such as osteoarthritis, arthritis, and diabetes-related metabolic conditions.

BiotechHealthtechLongevity

Investors · 5

Ulu VenturesPalo Alto · $2M
HKX Capitalreported · 2 sourcesLondon

Also in the syndicate · 3

Eli LillyEli Lilly and CompanyLifespan Vision Ventureslead

Funding

SEC filings, press & company announcements

$10M disclosed across 1 of 2 rounds · 2026

  • $10MSeries AAug 2026 · 5 sources

    Lifespan Vision Ventures (lead), Eli Lilly, Eli Lilly and Company, HKX Capital

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 3

by search overlap
Generate Biomedicines10 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
elevatebio9 shared keywordsElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.
RenBio8 shared keywordsRenBio develops DNA-based therapeutic technology that uses intramuscular injection of therapeutic-encoding "bioblueprints" so a patient's own muscle cells produce antibodies and therapeutic proteins to prevent and treat diseases, including infectious diseases. The company works in the antibody and therapeutic protein field, aiming to overcome obstacles in delivery, durability, and cost.

Companies competing with Remedium for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2023$275K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Remedium raises $10m for adjustable gene therapylongevity.technology · Aug 2026Remedium Bio Raises $10 Million Series A Led By Lifespan Vision Ventures With Participation From Eli Lilly And HKX Capitalpulse2.com · Aug 2026Lifespan Vision Ventures Leads Remedium Bio's Series A Financing - BioSpacebiospace.com · Aug 2026Remedium Bio Raises Initial Series A Funding to Advance Protein Therapeutics Platform | citybizcitybiz.co · Aug 2026Remedium Bio Raises $10M in Initial Series A Fundingfinsmes.com · Aug 2026Remedium Bio Closes $2.3M Expanded Seed Funding - FinSMEsfinsmes.com · Aug 2022

Frequently asked questions

What does Remedium do?
Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein. Its work targets diseases such as osteoarthritis, arthritis, and diabetes-related metabolic conditions.
Who are Remedium's investors?
Remedium's investors include Ulu Ventures, HKX Capital.
How much funding has Remedium raised?
Remedium has disclosed $10M raised across 1 of its 2 known rounds.
Where is Remedium headquartered?
Remedium is headquartered in Boston, US.